ROCCO, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 2.772
AS - Asia 235
NA - Nord America 105
SA - Sud America 17
AF - Africa 6
OC - Oceania 2
Totale 3.137
Nazione #
IT - Italia 2.713
US - Stati Uniti d'America 101
SG - Singapore 99
VN - Vietnam 53
CN - Cina 50
FR - Francia 20
DE - Germania 11
BD - Bangladesh 8
BR - Brasile 8
HK - Hong Kong 8
AR - Argentina 7
FI - Finlandia 5
GB - Regno Unito 5
JP - Giappone 5
IN - India 4
UA - Ucraina 4
NL - Olanda 3
RU - Federazione Russa 3
UZ - Uzbekistan 3
CH - Svizzera 2
ES - Italia 2
IQ - Iraq 2
KE - Kenya 2
PA - Panama 2
AU - Australia 1
CA - Canada 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
ID - Indonesia 1
IE - Irlanda 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
PE - Perù 1
PF - Polinesia Francese 1
PK - Pakistan 1
TN - Tunisia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 3.137
Città #
Genova 1.645
Genoa 640
Rapallo 266
Vado Ligure 154
Singapore 42
San Jose 27
Ashburn 24
Lauterbourg 17
Ho Chi Minh City 14
Beijing 10
Hanoi 10
Frankfurt am Main 9
Hong Kong 8
New York 6
Santa Clara 6
Helsinki 5
Haiphong 4
Los Angeles 4
Tokyo 4
Biên Hòa 3
Cardiff 3
Da Nang 3
Kyiv 3
Amsterdam 2
Atlanta 2
Bordighera 2
Buenos Aires 2
Des Moines 2
Dhaka 2
London 2
Madrid 2
Nairobi 2
Panama City 2
Paris 2
Vĩnh Tường 2
Zurich 2
Abidjan 1
Agadir 1
Araraquara 1
Athens 1
Belén de Escobar 1
Besançon 1
Bhopal 1
Bắc Giang 1
Camarillo 1
Campo Bom 1
Can Tho 1
Chennai 1
Chicago 1
Copenhagen 1
Cuenca 1
Del Viso 1
Denver 1
Dublin 1
Edison 1
Guernica 1
Gujrat 1
Houston 1
Hurlingham 1
Hải Dương 1
Johannesburg 1
Kilis 1
Kurgan 1
Lewes 1
Lima 1
Ludhiana 1
Mariënheem 1
Melitopol 1
Mexico City 1
Mississauga 1
Montepaone 1
Nanjing 1
Nha Trang 1
Ninh Bình 1
Novosibirsk 1
Offenbach 1
Papeete 1
Phoenix 1
Providence 1
Quảng Ninh 1
Rio de Janeiro 1
San Miguel de Tucumán 1
Santa Bárbara 1
Sidoarjo 1
Simão Dias 1
Sydney 1
São Carlos 1
Tashkent 1
Tianjin 1
Tunis 1
Tura 1
Ubá 1
União dos Palmares 1
Usinsk 1
Venice 1
Vĩnh Long 1
Totale 2.993
Nome #
APO866 activity in hematologic malignancies: a preclinical in vitro study. 245
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 200
Ras-induced resistance to lapatinib is overcome by MEK inhibition 199
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 199
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 191
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 189
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 189
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 182
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 178
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 173
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 169
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 165
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 160
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 156
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 154
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 146
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 143
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 111
Totale 3.149
Categoria #
all - tutte 9.255
article - articoli 9.255
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 14 26 14
2021/2022265 9 33 17 40 13 10 16 59 6 16 21 25
2022/2023336 39 47 1 35 58 45 2 18 45 0 42 4
2023/2024145 5 15 0 21 7 37 5 9 6 2 9 29
2024/2025416 12 28 11 32 54 25 33 83 16 18 40 64
2025/2026595 90 15 28 54 123 43 88 30 44 80 0 0
Totale 3.149